标题
Histone deacetylase 6 in health and disease
作者
关键词
-
出版物
Epigenomics
Volume 7, Issue 1, Pages 103-118
出版商
Future Medicine Ltd
发表日期
2015-02-17
DOI
10.2217/epi.14.69
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HDAC6 Deacetylates Ku70 and Regulates Ku70-Bax Binding in Neuroblastoma
- (2015) Chitra Subramanian et al. NEOPLASIA
- Plant-derived epigenetic modulators for cancer treatment and prevention
- (2014) Michael Schnekenburger et al. BIOTECHNOLOGY ADVANCES
- Limited efficacy of specific HDAC6 inhibition in urothelial cancer cells
- (2014) Lorena Rosik et al. CANCER BIOLOGY & THERAPY
- Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells
- (2014) Fengdong Cheng et al. MOLECULAR IMMUNOLOGY
- Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009
- (2014) I-N Hsieh et al. Cell Death & Disease
- Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition
- (2014) Maj-Linda Selenica et al. Alzheimers Research & Therapy
- LC3B-II deacetylation by histone deacetylase 6 is involved in serum-starvation-induced autophagic degradation
- (2013) Kun-Peng Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC
- (2013) Sridurga Mithraprabhu et al. BRITISH JOURNAL OF HAEMATOLOGY
- HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity
- (2013) Gang Ding et al. FEBS LETTERS
- Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects
- (2013) Santosh Vishwakarma et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Extracellular Signal-regulated Kinase (ERK) Phosphorylates Histone Deacetylase 6 (HDAC6) at Serine 1035 to Stimulate Cell Migration
- (2013) Kendra A. Williams et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
- (2013) Tint Lwin et al. JOURNAL OF CLINICAL INVESTIGATION
- Histone deacetylase 6–mediated selective autophagy regulates COPD-associated cilia dysfunction
- (2013) Hilaire C. Lam et al. JOURNAL OF CLINICAL INVESTIGATION
- Potent Histone Deacetylase Inhibitors Derived from 4-(Aminomethyl)-N-hydroxybenzamide with High Selectivity for the HDAC6 Isoform
- (2013) Christopher Blackburn et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development and Therapeutic Implications of Selective Histone Deacetylase 6 Inhibitors
- (2013) Jay H. Kalin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quinazolin-4-one Derivatives as Selective Histone Deacetylase-6 Inhibitors for the Treatment of Alzheimer’s Disease
- (2013) Chao-Wu Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
- (2013) Claudia Simões-Pires et al. Molecular Neurodegeneration
- Antidepressant-Like Properties of Novel HDAC6-Selective Inhibitors with Improved Brain Bioavailability
- (2013) Jeanine Jochems et al. NEUROPSYCHOPHARMACOLOGY
- Oncogenic Shp2 disturbs microtubule regulation to cause HDAC6-dependent ERK hyperactivation
- (2013) S-C Tien et al. ONCOGENE
- Development of a histone deacetylase 6 inhibitor and its biological effects
- (2013) J.-H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Largazole, a class I histone deacetylase inhibitor, enhances TNF-α-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts
- (2013) Salahuddin Ahmed et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Inhibition of Viral Pathogenesis and Promotion of the Septic Shock Response to Bacterial Infection by IRF-3 Are Regulated by the Acetylation and Phosphorylation of Its Coactivators
- (2013) S. Chattopadhyay et al. mBio
- MicroRNAs in cancer management and their modulation by dietary agents
- (2012) Tommy Karius et al. BIOCHEMICAL PHARMACOLOGY
- Chromatin-modifying agents in anti-cancer therapy
- (2012) Carole Seidel et al. BIOCHIMIE
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis
- (2012) E Kerr et al. CELL DEATH AND DIFFERENTIATION
- HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance
- (2012) Michaël Van Damme et al. Epigenetics
- Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer
- (2012) Kwang Hwa Jung et al. HEPATOLOGY
- Modulation of Histone Deacetylase 6 (HDAC6) Nuclear Import and Tubulin Deacetylase Activity through Acetylation
- (2012) Yuanjing Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth
- (2012) Joel A. Bergman et al. JOURNAL OF MEDICINAL CHEMISTRY
- HDAC6 as a target for antileukemic drugs in acute myeloid leukemia
- (2012) Björn Hackanson et al. LEUKEMIA RESEARCH
- HDAC6 Inhibitor Blocks Amyloid Beta-Induced Impairment of Mitochondrial Transport in Hippocampal Neurons
- (2012) Chaeyoung Kim et al. PLoS One
- T Cell Signaling Targets for Enhancing Regulatory or Effector Function
- (2012) F. Pan et al. Science Signaling
- Histone Deacetylases 6 and 9 and Sirtuin-1 Control Foxp3+ Regulatory T Cell Function Through Shared and Isoform-Specific Mechanisms
- (2012) U. H. Beier et al. Science Signaling
- Upregulation of miR-22 Promotes Osteogenic Differentiation and Inhibits Adipogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stem Cells by Repressing HDAC6 Protein Expression
- (2012) Shan Huang et al. STEM CELLS AND DEVELOPMENT
- A Novel Class of Small Molecule Inhibitors of HDAC6
- (2011) Elizabeth S. Inks et al. ACS Chemical Biology
- Regulation of Tat Acetylation and Transactivation Activity by the Microtubule-associated Deacetylase HDAC6
- (2011) Lihong Huo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protein Aggregates Are Recruited to Aggresome by Histone Deacetylase 6 via Unanchored Ubiquitin C Termini
- (2011) Hui Ouyang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protein kinase CK2 regulates the formation and clearance of aggresomes in response to stress
- (2011) M. Watabe et al. JOURNAL OF CELL SCIENCE
- Second-Generation Histone Deacetylase 6 Inhibitors Enhance the Immunosuppressive Effects of Foxp3+ T-Regulatory Cells
- (2011) Jay H. Kalin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3+ T-Regulatory Cells
- (2011) E. F. de Zoeten et al. MOLECULAR AND CELLULAR BIOLOGY
- The HTLV-1 Tax protein inhibits formation of stress granules by interacting with histone deacetylase 6
- (2011) S Legros et al. ONCOGENE
- Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease
- (2011) Anna Bobrowska et al. PLoS One
- Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo
- (2011) Valentina Zuco et al. PLoS One
- C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivo
- (2011) Q-y Zhu et al. Cell Death & Disease
- Requirement of a novel splicing variant of human histone deacetylase 6 for TGF-β1-mediated gene activation
- (2010) Yan Zhuang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes α-Tubulin Acetylation and Cell Differentiation
- (2010) Maralice Conacci-Sorrell et al. CELL
- HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy
- (2010) Joo-Yong Lee et al. EMBO JOURNAL
- Enhanced acetylation of alpha-tubulin in influenza A virus infected epithelial cells
- (2010) Matloob Husain et al. FEBS LETTERS
- A mutation in the 3′-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia
- (2010) Delphine Simon et al. HUMAN MOLECULAR GENETICS
- The Role of HDAC6 in Cancer
- (2010) Grace I. Aldana-Masangkay et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy
- (2010) Joo-Yong Lee et al. JOURNAL OF CELL BIOLOGY
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
- (2010) Kyle V. Butler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Drosophila Histone Deacetylase 6 Protects Dopaminergic Neurons against α-Synuclein Toxicity by Promoting Inclusion Formation
- (2010) Guiping Du et al. MOLECULAR BIOLOGY OF THE CELL
- Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents
- (2010) M. Namdar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity
- (2009) Younho Han et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Elongator Controls the Migration and Differentiation of Cortical Neurons through Acetylation of α-Tubulin
- (2009) Catherine Creppe et al. CELL
- Function of Histone Deacetylase 6 as a Cofactor of Nuclear Receptor Coregulator LCoR
- (2009) Ana Palijan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: Potential role of histone deacetylase 6
- (2009) In Ah Kim et al. RADIOTHERAPY AND ONCOLOGY
- Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors
- (2008) David V. Smil et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells
- (2008) R. Rao et al. BLOOD
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis
- (2008) Y.-S. Lee et al. CANCER RESEARCH
- Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor
- (2008) M. Bazzaro et al. CLINICAL CANCER RESEARCH
- Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
- (2008) L Marquard et al. HISTOPATHOLOGY
- Use of the Nitrile Oxide Cycloaddition (NOC) Reaction for Molecular Probe Generation: A New Class of Enzyme Selective Histone Deacetylase Inhibitors (HDACIs) Showing Picomolar Activity at HDAC6
- (2008) Alan P. Kozikowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Series of Potent and Selective, Triazolylphenyl-Based Histone Deacetylases Inhibitors with Activity against Pancreatic Cancer Cells andPlasmodium falciparum
- (2008) Yufeng Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Deacetylation of cortactin by SIRT1 promotes cell migration
- (2008) Y Zhang et al. ONCOGENE
- HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation
- (2008) R. B. Parmigiani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs)
- (2007) Stefan Schäfer et al. BIOORGANIC & MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started